Makeieff Marc, Venegoni Delphine, Mercante Guisepe, Crampette Louis, Guerrier Bernard
Department of Otolaryngology-Head and Neck Surgery, Hopital Gui de Chauliac, University of Medecine, Montpellier 34295, France.
Laryngoscope. 2005 Feb;115(2):353-7. doi: 10.1097/01.mlg.0000154751.86431.41.
Conservation of laryngeal function is a key surgical objective in cases of limited recurrence after previously irradiated T1b or T2 glottic carcinoma. Only a few articles have mentioned the use of supracricoid partial laryngectomies (SCPL) to treat recurrent T1/T2 tumors that cannot be managed with vertical partial laryngectomy.
To evaluate oncologic and functional results of SCPL in selected cases of T1/T2 glottic carcinoma recurrence after primary irradiation therapy.
Between 1986 and 2000, 23 selected patients (T1b, 12 cases; T2, 11 cases) underwent SCPL as salvage treatment: cricohyoidepiglottopexy (CHEP) in 18 cases and cricohyodopexy (CHP) in 5 cases.
The mean cannulation time was 28 (14-90) days. The mean nasogastric feeding tube time for CHP and CHEP was 55 (28-96) days and 21 (9-45) days, respectively. Four (17.4%) patients had major swallowing recovery problems. Three patients died in the postoperative period, one of intercurrent disease and two because of aspiration pneumonia. Six (26.08%) patients relapsed and underwent total laryngectomy. Three were subsequently controlled. The T stage was correlated with the onset of a new recurrence (P = .0258). The surgical margins were not correlated with recurrence (P = .0741). At 3 and 5 years, the global survival rate was 82.9% and 69.04%. The success rate for oncologic control and oncologic control with organ preservation was 74% and 66.6%, respectively.
In selected cases of limited recurrence after radiation therapy for T1/T2 vocal cord carcinomas, SCPL can be an alternative to total laryngectomy when partial vertical surgery appears unsuitable.
保留喉功能是先前接受过放疗的T1b或T2声门癌有限复发病例的关键手术目标。仅有少数文章提及使用环状软骨上部分喉切除术(SCPL)治疗无法通过垂直部分喉切除术处理的复发性T1/T2肿瘤。
评估SCPL治疗原发性放疗后T1/T2声门癌复发的特定病例的肿瘤学和功能结果。
1986年至2000年期间,23例选定患者(T1b,12例;T2,11例)接受SCPL作为挽救性治疗:18例行环舌会厌固定术(CHEP),5例行环舌固定术(CHP)。
平均插管时间为28(14 - 90)天。CHP和CHEP的平均鼻饲管留置时间分别为55(28 - 96)天和21(9 - 45)天。4例(17.4%)患者存在严重吞咽恢复问题。3例患者在术后死亡,1例死于并发疾病,2例死于吸入性肺炎。6例(26.08%)患者复发并接受了全喉切除术。其中3例随后得到控制。T分期与新复发的发生相关(P = 0.0258)。手术切缘与复发无关(P = 0.0741)。3年和5年时,总生存率分别为82.9%和69.04%。肿瘤学控制成功率和保留器官的肿瘤学控制成功率分别为74%和66.6%。
在T1/T2声带癌放疗后有限复发的特定病例中,当部分垂直手术不合适时,SCPL可作为全喉切除术的替代方法。